No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.
No article has been written about this topic yet.
Be the first one to add some text.
Loading AI-assisted edit mode...
Timeline
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
125,000,000
April 2019
103,000,000
September 2017
125,000,000
April 1, 2019
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Krystle Vermes
May 29, 2020
BioSpace
The data, which was presented at the American Society of Clinical Oncology annual meeting, looked into the use of ALLO-501 for relapsed/refractory non-Hodgkin lymphoma.
BioSpace
May 26, 2020
BioSpace
SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, announced the appointment of Julie Hambleton, M.D. to the Company's Board of Directors.
Is a
Company attributes
Industry
Founder
Crunchbase
Legal name
SpringWorks Therapeutics, LLC
Founded date
2017
Total funding amount (USD)
353,000,000
Other attributes
Headquarters
Categories
Related Topics
Contributors
- 1
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 2
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 3
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 4
Marie Gabrielle Laguna-Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur